Different methods of perfusate administration do not have an effect on synovial concentrations of amikacin following intravenous regional limb perfusion
American Journal of Veterinary Research · 2025
DOI: 10.2460/ajvr.24.12.0399 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2025. Verfasst von Stephanie Ortiz Gutierrez und 4 weiteren Autor:innen. Beteiligte Einrichtung: William R. Pritchard Veterinary Medical Teaching Hospital, University of California-Davis, Davis, CA. Hauptthemen laut MEDLINE: Amikacin, Synovial Fluid, Anti-Bacterial Agents, Perfusion. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To determine if different methods of perfusate instillation influence synovial amikacin concentrations in the radiocarpal joint (RCJ) after IV regional limb perfusion (IVRLP).
Methods
6 healthy horses received an IVRLP using 2 different methods: (1) 2 g amikacin followed by 52 mL 0.9% NaCl (60 mL total; perfusate-A) and (2) 2 g amikacin diluted to 60 mL with 0.9% NaCl (perfusate-D). For both methods, the perfusion was administered over 5 minutes. Joint fluid from the RCJ was sampled at 10, 15, 20, 25, and 30 minutes after instillation of the perfusate. Systemic concentrations of amikacin were measured prior to IVRLP; at 5, 10, 15, 20, 25, and 29 minutes; and 1 minute after tourniquet removal. Amikacin concentrations were determined by fluorescence polarization immunoassay.
Results
Mean ± SD peak synovial concentration in the RCJ was 1,447 ± 1,134 μg/mL with perfusate-D and 1,170 ± 977 μg/mL with perfusate-A. Mean ± SD time to peak concentration was 18 ± 7 minutes with perfusate-D and 20 ± 5 minutes with perfusate-A. There was no difference in peak synovial concentration ( P = .684) and time to peak concentration ( P = .732) between groups. There was no difference in systemic amikacin concentrations over time between groups ( P = .196). All horses included reached the target synovial amikacin concentration of > 160 μg/mL.
Conclusions
There was no difference in the systemic or the synovial concentrations of amikacin using different methods of perfusate administration. Clinical Relevance Different methods of perfusate administration did not affect synovial concentrations of amikacin achieved when performing IVRLP. There is no advantage to administering amikacin first.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- William R. Pritchard Veterinary Medical Teaching Hospital, University of California-Davis, Davis, CA.
- Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, CA.
ORCID-Profile: Laurel K Saldinger
Zitieren
APA
Gutierrez, S. O., Kilcoyne, I., Saldinger, L. K., Woodward, L., & Nieto, J. E. (2025). Different methods of perfusate administration do not have an effect on synovial concentrations of amikacin following intravenous regional limb perfusion. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.24.12.0399
Vancouver
Gutierrez SO, Kilcoyne I, Saldinger LK, Woodward L, Nieto JE. Different methods of perfusate administration do not have an effect on synovial concentrations of amikacin following intravenous regional limb perfusion. American Journal of Veterinary Research. 2025. doi:10.2460/ajvr.24.12.0399
BibTeX
@article{Gutierrez2025,
author = {Gutierrez, Stephanie Ortiz and Kilcoyne, Isabelle and Saldinger, Laurel K and Woodward, Lucy and Nieto, Jorge E},
title = {Different methods of perfusate administration do not have an effect on synovial concentrations of amikacin following intravenous regional limb perfusion},
journal = {American Journal of Veterinary Research},
year = {2025},
doi = {10.2460/ajvr.24.12.0399}
}
EUVIMED